fig2
Figure 2. What biomarkers should we use in clinical practice? *not useful in female patients with late-onset phenotype; **characteristic pattern in FD; ***to predict treatment response; Lyso-Gb3: Globotriaosylsphingosine; TDI: tissue Doppler imaging; LGE: late gadolinium enhancement; eGFR: estimated GFR; MRI: magnetic resonance imaging.
